Home › Compare › CSOL vs JNJ

CSOL vs JNJ: Dividend Comparison 2026

CSOL yields 6688.96% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CSOL wins by $1062234097834972.13M in total portfolio value
10 years
CSOL
CSOL
● Live price
6688.96%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1062234097834972.13M
Annual income
$1,031,887,410,955,555,200,000.00
Full CSOL calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CSOL vs JNJ

📍 CSOL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSOLJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSOL + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CSOL pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSOL
Annual income on $10K today (after 15% tax)
$568,561.87/yr
After 10yr DRIP, annual income (after tax)
$877,104,299,312,221,900,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CSOL beats the other by $877,104,299,312,221,900,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSOL + JNJ for your $10,000?

CSOL: 50%JNJ: 50%
100% JNJ50/50100% CSOL
Portfolio after 10yr
$531117048917486.06M
Annual income
$515,943,705,477,777,600,000.00/yr
Blended yield
97.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CSOL
No analyst data
Altman Z
0.3
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSOL buys
0
JNJ buys
0
No recent congressional trades found for CSOL or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSOLJNJ
Forward yield6688.96% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$1062234097834972.13M ✓$20.0K
Annual income after 10y$1,031,887,410,955,555,200,000.00 ✓$827.78
Total dividends collected$1060197980964661.88M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CSOL vs JNJ ($10,000, DRIP)

YearCSOL PortfolioCSOL Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$679,596$668,896.32$10,676$355.77+$668.9K → CSOL
2$43,211,232$42,484,063.46$11,407$389.39+$43.20M → CSOL
3$2,570,808,801$2,524,572,782.97$12,198$426.53+$2570.80M → CSOL
4$143,121,719,657$140,370,954,240.63$13,056$467.62+$143121.71M → CSOL
5$7,456,610,117,399$7,303,469,877,365.59$13,987$513.12+$7456610.10M → CSOL
6$363,594,623,628,531$355,616,050,802,913.70$14,998$563.56+$363594623.61M → CSOL
7$16,594,962,640,350,284$16,205,916,393,067,752.00$16,098$619.52+$16594962640.33M → CSOL
8$709,028,095,032,704,500$691,271,485,007,529,700.00$17,295$681.69+$709028095032.69M → CSOL
9$28,361,389,606,931,763,000$27,602,729,545,246,765,000.00$18,599$750.82+$28361389606931.74M → CSOL
10$1,062,234,097,834,972,200,000$1,031,887,410,955,555,200,000.00$20,022$827.78+$1062234097834972.13M → CSOL

CSOL vs JNJ: Complete Analysis 2026

CSOL — Stock

China Solar & Clean Energy Solutions, Inc., through its subsidiaries, designs and provides integrated renewable energy solutions for industrial clients and real estate developers in China and internationally. The company offers evacuated tubular and flat plate solar water heaters; biomass stove; and spacing heating devices along with industrial waste heat recovery systems, including hot tube heat exchanger, high temperature hot air furnace, heat pipe evaporator, dust removal and desulfurization system, and constant pressure hot water boiler, as well as smokeless coal-fired boilers and bio-materials furnaces. It also provides industrial waste heat recovery systems, as well as heating products, such as heating pipes, heat exchangers, specialty heating pipes and tubes, high temperature hot blast stoves, heating filters, normal pressure water boilers, and radiators. In addition, the company offers densely covered regular tubular heaters; and sells spare parts for its products, as well as provides after-sales maintenance and repair services. China Solar & Clean Energy Solutions sells its products through a network of distributors, wholesalers, sales agents, and retailers. The company is based in Lake Mary, Florida.

Full CSOL Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CSOL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSOL vs SCHDCSOL vs JEPICSOL vs OCSOL vs KOCSOL vs MAINCSOL vs ABBVCSOL vs MRKCSOL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.